UCLA Neuro-Oncology Program
Los Angeles, California, United States
Medical group in Los Angeles, California
710 Westwood Plaza, Los Angeles, CA 90024
About UCLA Neuro-Oncology Program
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at UCLA Neuro-Oncology Program
During the past decade, UCLA Neuro-Oncology Program conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
2008-10-16
2029-09-20
Recruiting
720
A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)
2013-04-03
2025-04-03
Active, not recruiting
1,487
Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer
2013-05-01
2021-01-01
Completed
682
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer
2014-01-31
2021-06-04
Completed
1,846
Therapy Management With Nab-Paclitaxel in Daily Routine
2015-12-01
2021-12-01
Unknown status
1,200
Pertuzumab in First Line Treatment of HER2-positive Metastatic Breast Cancer Patients
2016-03-01
2020-07-01
Unknown status
300
Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line
2018-05-24
2022-11-30
Completed
41
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer
2018-06-14
2023-11-16
Active, not recruiting
500
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Neuro-Oncology Program"
#1 collaborator was "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at UCLA Neuro-Oncology Program
According to Clinical.Site data, the most researched conditions in "UCLA Neuro-Oncology Program" are
"Glioblastoma Multiforme" (3 trials), "Multiple Myeloma" (2 trials), "Brain Cancer" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials) and "Glioblastoma" (1 trials). Many other conditions were trialed in "UCLA Neuro-Oncology Program" in a lesser frequency.
Clinical Trials Intervention Types at UCLA Neuro-Oncology Program
Most popular intervention types in "UCLA Neuro-Oncology Program" are "Drug" (5 trials), "Biological" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Nivolumab" (2 trials), "Bevacizumab" (1 trials), "CC-122" (1 trials), "CC-223" (1 trials) and "Carmustine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UCLA Neuro-Oncology Program
The vast majority of trials in "UCLA Neuro-Oncology Program" are
6 trials for "All" genders.
Clinical Trials Status at UCLA Neuro-Oncology Program
Currently, there are NaN active trials in "UCLA Neuro-Oncology Program".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in UCLA Neuro-Oncology Program,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in UCLA Neuro-Oncology Program, 3 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".